Login / Signup

Dual Role of a Novel Heteroleptic Cu(I) Complex in Visible-Light-Driven CO 2 Reduction.

Cecilia BruschiXin GuiPascal RautheOliver FuhrAndreas-Neil UnterreinerWillem KlopperClaudia Bizzarri
Published in: Chemistry (Weinheim an der Bergstrasse, Germany) (2024)
A novel mononuclear Cu(I) complex was synthesized via coordination with a benzoquinoxalin-2'-one-1,2,3-triazole chelating diimine and the bis[(2-diphenylphosphino)phenyl] ether (DPEPhos), to target a new and efficient photosensitizer for photocatalytic CO 2 reduction. The Cu(I) complex absorbs in the blue-green region of the visible spectrum, with a broad band having a maximum at 475 nm (ϵ =4500 M -1  cm -1 ), which is assigned to the metal-to-ligand charge transfer (MLCT) transition from the Cu(I) to the benzoquinoxalin-2'-one moiety of the diimine. Surprisingly, photo-driven experiments for the CO 2 reduction showed that this complex can undergo a photoinduced electron transfer with a sacrificial electron donor and accumulate electrons on the diimine backbone. Photo-driven experiments in a CO 2 atmosphere revealed that this complex can not only act as a photosensitizer, when combined with an Fe(III)-porphyrin, but can also selectively produce CO from CO 2 . Thus, owing to its charge-accumulation properties, the non-innocent benzoquinoxalin-2-one based ligand enabled the development of the first copper(I)-based photocatalyst for CO 2 reduction.
Keyphrases
  • electron transfer
  • visible light
  • photodynamic therapy
  • metal organic framework
  • aqueous solution
  • highly efficient
  • single cell
  • peripheral blood
  • oxide nanoparticles
  • solar cells
  • light emitting